Iovance Biotherapeutics
IOVA
$4.11
+11.08%
Related headlines
IOVA price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Iovance Biotherapeutics's 12-month outlook, with a consensus price target around $5.34 and implied upside of +29.9% versus the current price.
Average Target
$5.34
3 analysts
Implied Upside
+29.9%
vs. current price
Analyst Count
3
covering this stock
Price Range
$3 - $5
Analyst target range
IOVA Technical Analysis
Beta
0.69
0.69x market volatility
Max Drawdown
-54.4%
Largest decline past year
52-Week Range
$2-$6
Price range past year
Annual Return
+134.9%
Cumulative gain past year
| Period | IOVA Return | S&P 500 |
|---|---|---|
| 1m | +16.4% | +4.8% |
| 3m | +43.2% | +8.2% |
| 6m | +83.5% | +13.1% |
| 1y | +134.9% | +27.9% |
| ytd | +63.1% | +9.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is IOVA Overvalued?
PE
-2.5x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-2.4x
Enterprise Value Multiple
